Does ANTI-INHIBITOR COAGULANT COMPLEX Cause Therapy partial responder? 104 Reports in FDA Database

Q: Does ANTI-INHIBITOR COAGULANT COMPLEX cause Therapy partial responder?

104 reports of Therapy partial responder have been filed with the FDA for ANTI-INHIBITOR COAGULANT COMPLEX, representing 7.2% of all ANTI-INHIBITOR COAGULANT COMPLEX adverse event reports.

Q: How dangerous is Therapy partial responder from ANTI-INHIBITOR COAGULANT COMPLEX?

Of 104 reports, 72 (69.2%) resulted in death and 21 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Therapy partial responder have been filed in association with ANTI-INHIBITOR COAGULANT COMPLEX (FEIBA). This represents 7.2% of all adverse event reports for ANTI-INHIBITOR COAGULANT COMPLEX.

104

Reports of Therapy partial responder with ANTI-INHIBITOR COAGULANT COMPLEX

7.2%

of all ANTI-INHIBITOR COAGULANT COMPLEX reports

Deaths

Hospitalizations

How Dangerous Is Therapy partial responder From ANTI-INHIBITOR COAGULANT COMPLEX?

Of the 104 reports, 72 (69.2%) resulted in death, 21 (20.2%) required hospitalization.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ANTI-INHIBITOR COAGULANT COMPLEX. However, 104 reports have been filed with the FAERS database.

What Other Side Effects Does ANTI-INHIBITOR COAGULANT COMPLEX Cause?

Haemorrhage (380) Treatment failure (135) Drug ineffective (129) Haemarthrosis (92) Acquired haemophilia (77) Pre-existing disease (74) Death (59) Factor viii inhibition (56) Anti factor viii antibody positive (49) Joint swelling (45)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which ANTI-INHIBITOR COAGULANT COMPLEX Alternatives Have Lower Therapy partial responder Risk?

ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR HUMAN ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT

ANTI-INHIBITOR COAGULANT COMPLEX Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder ANTI-INHIBITOR COAGULANT COMPLEX Demographics